Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NSE - Delayed Quote INR

Fairchem Organics Limited (FAIRCHEMOR.NS)

Compare
884.95
-22.90
(-2.52%)
At close: April 4 at 3:29:11 PM GMT+5:30
Loading Chart for FAIRCHEMOR.NS
  • Previous Close 907.85
  • Open 910.15
  • Bid --
  • Ask 883.40 x --
  • Day's Range 857.00 - 911.50
  • 52 Week Range 774.10 - 1,553.00
  • Volume 15,092
  • Avg. Volume 26,051
  • Market Cap (intraday) 11.523B
  • Beta (5Y Monthly) -0.13
  • PE Ratio (TTM) 34.79
  • EPS (TTM) 25.44
  • Earnings Date --
  • Forward Dividend & Yield 7.50 (0.85%)
  • Ex-Dividend Date Jul 29, 2024
  • 1y Target Est --

Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, North America, and internationally. It provides nutraceuticals comprising natural and mixed tocopherol and sterol concentrates; and oleo chemicals, such as dimer, isostearic, monobasic, linoleic/soya fatty, monomer, stearic, palmitic, and distilled fatty acid products, as well as residues. The company was incorporated in 2019 and is based in Ahmedabad, India. Fairchem Organics Limited is a subsidiary of Fih Mauritius Investments Limited.

www.fairchem.in

227

Full Time Employees

March 31

Fiscal Year Ends

Recent News: FAIRCHEMOR.NS

View More

Performance Overview: FAIRCHEMOR.NS

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

FAIRCHEMOR.NS
27.39%
S&P BSE SENSEX (^BSESN)
3.55%

1-Year Return

FAIRCHEMOR.NS
31.81%
S&P BSE SENSEX (^BSESN)
1.53%

3-Year Return

FAIRCHEMOR.NS
45.20%
S&P BSE SENSEX (^BSESN)
24.34%

5-Year Return

FAIRCHEMOR.NS
34.08%
S&P BSE SENSEX (^BSESN)
173.15%

Compare To: FAIRCHEMOR.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FAIRCHEMOR.NS

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    11.49B

  • Enterprise Value

    11.93B

  • Trailing P/E

    34.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.00

  • Price/Book (mrq)

    3.86

  • Enterprise Value/Revenue

    2.08

  • Enterprise Value/EBITDA

    20.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.74%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.78B

  • Net Income Avi to Common (ttm)

    331.42M

  • Diluted EPS (ttm)

    25.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.27M

  • Total Debt/Equity (mrq)

    14.88%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: FAIRCHEMOR.NS

View More

Company Insights: FAIRCHEMOR.NS

Research Reports: FAIRCHEMOR.NS

View More

People Also Watch